ORKA

Oruka Therapeutics is a biotechnology company developing drugs made from monoclonal antibodies, which are proteins designed to fight specific targets in the immune system. The company is testing treatments for psoriasis, a skin condition, and other inflammatory diseases. Their main drugs are still in clinical trials, meaning they are being tested in patients but not yet approved by regulators. The company is based in Menlo Park, California.